Expression and purification of recombinant human α-defensins in Escherichia coli

Protein Expression and Purification

Volumn 49, Issue 1, 2006, Pages 1-8

  Pazgier, Marzena ^a   Lubkowski, Jacek ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antibacterial activity; Expression; Fusion protein; Human defensins; Purification

Indexed keywords

ALPHA DEFENSIN; ANTIINFECTIVE AGENT; PEPTIDE FRAGMENT; RECOMBINANT PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; DRUG EFFECT; ESCHERICHIA COLI; GENE EXPRESSION; GENE VECTOR; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PROTEIN FOLDING; SEQUENCE ALIGNMENT;

ALPHA-DEFENSINS; AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; CONSERVED SEQUENCE; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PEPTIDE FRAGMENTS; PROTEIN FOLDING; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT;

ESCHERICHIA COLI;

EID: 33747757981     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.05.004     Document Type: Article

References (69)

1. Beisswenger C., and Bals R. Functions of antimicrobial peptides in host defense and immunity. Curr. Protein Pept. Sci. 6 (2005) 255-264
2. Yang D., Biragyn A., Hoover D.M., Lubkowski J., and Oppenheim J.J. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense. Annu. Rev. Immunol. 22 (2004) 181-215
3. Ganz T., Selsted M.E., Szklarek D., Harwig S.S., Daher K., Bainton D.F., and Lehrer R.I. Defensins: natural peptide antibiotics of human neutrophils. J. Clin. Invest. 76 (1985) 1427-1435
4. Ganz T., Oren A., and Lehrer R.I. Defensins: microbicidal and cytotoxic peptides of mammalian host defense cells. Med. Microbiol. Immunol. (Berl) 181 (1992) 99-105
5. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 415 (2002) 389-395
6. Zasloff M. Antimicrobial peptides in health and disease. N. Engl. J. Med. 347 (2002) 1199-1200
7. Izadpanah A., and Gallo R.L. Antimicrobial peptides. J. Am. Acad. Dermatol. 52 (2005) 381-390
8. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3 (2003) 710-720
9. Eckmann L. Defence molecules in intestinal innate immunity against bacterial infections. Curr. Opin. Gastroenterol. 21 (2005) 147-151
10. Chang T.L., and Klotman M.E. Defensins: natural anti-HIV peptides. AIDS Rev. 6 (2004) 161-168
11. Territo M.C., Ganz T., Selsted M.E., and Lehrer R. Monocyte-chemotactic activity of defensins from human neutrophils. J. Clin. Invest. 84 (1989) 2017-2020
12. Chertov O., Michiel D.F., Xu L., Wang J.M., Tani K., Murphy W.J., Longo D.L., Taub D.D., and Oppenheim J.J. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271 (1996) 2935-2940
13. Yang D., Chen Q., Chertov O., and Oppenheim J.J. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J. Leukoc. Biol. 68 (2000) 9-14
14. Yang D., Biragyn A., Kwak L.W., and Oppenheim J.J. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol. 23 (2002) 291-296
15. Chang T.L., Vargas Jr. J., DelPortillo A., and Klotman M.E. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J. Clin. Invest. 115 (2005) 765-773
16. Quinones-Mateu M.E., Lederman M.M., Feng Z., Chakraborty B., Weber J., Rangel H.R., Marotta M.L., Mirza M., Jiang B., Kiser P., Medvik K., Sieg S.F., and Weinberg A. Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS 17 (2003) F39-F48
17. Chang T.L., Francois F., Mosoian A., and Klotman M.E. CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J. Virol. 77 (2003) 6777-6784
18. Mackewicz C.E., Yuan J., Tran P., Diaz L., Mack E., Selsted M.E., and Levy J.A. α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS 17 (2003) F23-F32
19. Zhang L., Yu W., He T., Yu J., Caffrey R.E., Dalmasso E.A., Fu S., Pham T., Mei J., Ho J.J., Zhang W., Lopez P., and Ho D.D. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298 (2002) 995-1000
20. Mallow E.B., Harris A., Salzman N., Russell J.P., DeBerardinis R.J., Ruchelli E., and Bevins C.L. Human enteric defensins: gene structure and developmental expression. J. Biol. Chem. 271 (1996) 4038-4045
21. Bevins C.L., Jones D.E., Dutra A., Schaffzin J., and Muenke M. Human enteric defensin genes: chromosomal map position and a model for possible evolutionary relationships. Genomics 31 (1996) 95-106
22. Wilde C.G., Griffith J.E., Marra M.N., Snable J.L., and Scott R.W. Purification and characterization of human neutrophil peptide 4, a novel member of the defensin family. J. Biol. Chem. 264 (1989) 11200-11203
23. Jones D.E., and Bevins C.L. Paneth cells of the human small intestine express an antimicrobial peptide gene. J. Biol. Chem. 267 (1992) 23216-23225
24. Jones D.E., and Bevins C.L. Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel. FEBS Lett. 315 (1993) 187-192
25. Ghosh D., Porter E., Shen B., Lee S.K., Wilk D., Drazba J., Yadav S.P., Crabb J.W., Ganz T., and Bevins C.L. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 3 (2002) 583-590
26. Valore E.V., Martin E., Harwig S.S., and Ganz T. Intramolecular inhibition of human defensin HNP-1 by its propiece. J. Clin. Invest. 97 (1996) 1624-1629
27. Porter E.M., Poles M.A., Lee J.S., Naitoh J., Bevins C.L., and Ganz T. Isolation of human intestinal defensins from ileal neobladder urine. FEBS Lett. 434 (1998) 272-276
28. Selsted M.E., and Harwig S.S. Determination of the disulfide array in the human defensin HNP-2. A covalently cyclized peptide. J. Biol. Chem. 264 (1989) 4003-4007
29. Hill C.P., Yee J., Selsted M.E., and Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science 251 (1991) 1481-1485
30. Maemoto A., Qu X., Rosengren K.J., Tanabe H., Henschen-Edman A., Craik D.J., and Ouellette A.J. Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4. J. Biol. Chem. 279 (2004) 44188-44196
31. Pardi A., Zhang X.L., Selsted M.E., Skalicky J.J., and Yip P.F. NMR studies of defensin antimicrobial peptides. 2. Three-dimensional structures of rabbit NP-2 and human HNP-1. Biochemistry 31 (1992) 11357-11364
32. Mandal M., and Nagaraj R. Antibacterial activities and conformations of synthetic alpha-defensin HNP-1 and analogs with one, two, and three disulfide bridges. J. Pept. Res. 59 (2002) 95-104
33. Valore E.V., and Ganz T. Laboratory production of antimicrobial peptides in native conformation. Methods Mol. Biol. 78 (1997) 115-131
34. Piers K.L., Brown M.H., and Hancock R.E. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 134 (1993) 7-13
35. Cabral K.M., Almeida M.S., Valente A.P., Almeida F.C., and Kurtenbach E. Production of the active antifungal Pisum sativum defensin 1 (Psd1) in Pichia pastoris: overcoming the inefficiency of the STE13 protease. Protein Express. Purif. 31 (2003) 115-122
36. Zhang L., Falla T., Wu M., Fidai S., Burian J., Kay W., and Hancock R.E. Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria. Biochem. Biophys. Res. Commun. 247 (1998) 674-680
37. Wei Q., Kim Y.S., Seo J.H., Jang W.S., Lee I.H., and Cha H.J. Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli. Appl. Environ. Microbiol. 71 (2005) 5038-5043
38. Rao X.C., Li S., Hu J.C., Jin X.L., Hu X.M., Huang J.J., Chen Z.J., Zhu J.M., and Hu F.Q. A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli. Protein Express. Purif. 36 (2004) 11-18
39. Haught C., Davis G.D., Subramanian R., Jackson K.W., and Harrison R.G. Recombinant production and purification of novel antisense antimicrobial peptide in Escherichia coli. Biotechnol. Bioeng. 57 (1998) 55-61
40. Fairlie W.D., Uboldi A.D., De Souza D.P., Hemmings G.J., Nicola N.A., and Baca M. A fusion protein system for the recombinant production of short disulfide-containing peptides. Protein Express. Purif. 26 (2002) 171-178
41. Dobeli H., Andres H., Breyer N., Draeger N., Sizmann D., Zuber M.T., Weinert B., and Wipf B. Recombinant fusion proteins for the industrial production of disulfide bridge containing peptides: purification, oxidation without concatamer formation, and selective cleavage. Protein Express. Purif. 12 (1998) 404-414
42. Xu Z., Wang F., Peng L., Fang X., and Cen P. Expression of human beta-defensin-2 with multiple joined genes in Escherichia coli. Appl. Biochem. Biotechnol. 120 (2005) 1-13
43. Wang F., Fang X., Xu Z., Peng L., and Cen P. Fusion expression of human beta-defensin-2 from multiple joined genes in Escherichia coli. Prep. Biochem. Biotechnol. 34 (2004) 215-225
44. Peng L., Xu Z., Fang X., Wang F., Yang S., and Cen P. Preferential codons enhancing the expression level of human beta-defensin-2 in recombinant Escherichia coli. Protein Pept. Lett. 11 (2004) 339-344
45. Fang X., Peng L., Xu Z., Wu J., and Cen P. Cloning and expression of human beta-defensin-2 gene in Escherichia coli. Protein Pept. Lett. 9 (2002) 31-37
46. Cipakova I., Hostinova E., Gasperik J., and Velebny V. High-level expression and purification of a recombinant hBD-1 fused to LMM protein in Escherichia coli. Protein Express. Purif. 37 (2004) 207-212
47. Xu Z., Chen H., Yin X., Xu N., and Cen P. High-level expression of soluble human beta-defensin-2 fused with green fluorescent protein in Escherichia coli cell-free system. Appl. Biochem. Biotechnol. 127 (2005) 53-62
48. Chen H., Xu Z., Peng L., Fang X., Yin X., Xu N., and Cen P. Recent advances in the research and development of human defensins. Peptides (2005)
49. Porter E.M., van Dam E., Valore E.V., and Ganz T. Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect. Immun. 65 (1997) 2396-2401
50. Yansura D.G. Expression as trpE fusion. Methods Enzymol. 185 (1990) 161-166
51. Miozzari G.F., and Yanofsky C. Translation of the leader region of the Escherichia coli tryptophan operon. J. Bacteriol. 133 (1978) 1457-1466
52. Studier F.W., Rosenberg A.H., Dunn J.J., and Dubendorff J.W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185 (1990) 60-89
53. Hoover D.M., and Lubkowski J. DNAWorks: an automated method for designing oligonucleotides for PCR-based gene synthesis. Nucleic Acids Res. 30 (2002) e43
54. Staley J.P., and Kim P.S. Formation of a native-like subdomain in a partially folded intermediate of bovine pancreatic trypsin inhibitor. Protein Sci. 3 (1994) 1822-1832
55. D.S. Doering, Functional and structural studies of a small F-actin binding domain. PhD thesis, Massachusetts Institute of Technology, Cambridge, USA, MA (1992).
56. Gross E., and Morell J.L. The reaction of cyanogen bromide with S-methylcysteine: fragmentation of the peptide 14-29 of bovine pancreatic ribonuclease A. Biochem. Biophys. Res. Commun. 59 (1974) 1145-1150
57. Wu Z., Powell R., and Lu W. Productive folding of human neutrophil alpha-defensins in vitro without the pro-peptide. J. Am. Chem. Soc. 125 (2003) 2402-2403
58. Wu Z., Ericksen B., Tucker K., Lubkowski J., and Lu W. Synthesis and characterization of human alpha-defensins 4-6. J. Pept. Res. 64 (2004) 118-125
59. Harwig S.S., Ganz T., and Lehrer R.I. Neutrophil defensins: purification, characterization, and antimicrobial testing. Methods Enzymol. 236 (1994) 160-172
60. Ouellette IV A.J. Paneth cell antimicrobial peptides and the biology of the mucosal barrier. Am. J. Physiol. 277 (1999) G257-G261
61. Ouellette A.J., and Selsted M.E. Paneth cell defensins: endogenous peptide components of intestinal host defense. FASEB J. 10 (1996) 1280-1289
62. Raj P.A., Antonyraj K.J., and Karunakaran T. Large-scale synthesis and functional elements for the antimicrobial activity of defensins. Biochem. J. 347 Pt 3 (2000) 633-641
63. Valore E.V., and Ganz T. Posttranslational processing of defensins in immature human myeloid cells. Blood 79 (1992) 1538-1544
64. Harwig S.S., Park A.S., and Lehrer R.I. Characterization of defensin precursors in mature human neutrophils. Blood 79 (1992) 1532-1537
65. Kohno T., Kusunoki H., Sato K., and Wakamatsu K. A new general method for the biosynthesis of stable isotope-enriched peptides using a decahistidine-tagged ubiquitin fusion system: an application to the production of mastoparan-X uniformly enriched with 15N and 15N/13C. J. Biomol. NMR 12 (1998) 109-121
66. Kleid D.G., Yansura D., Small B., Dowbenko D., Moore D.M., Grubman M.J., McKercher P.D., Morgan D.O., Robertson B.H., and Bachrach H.L. Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214 (1981) 1125-1129
67. Fischer B.E. Renaturation of recombinant proteins produced as inclusion bodies. Biotechnol. Adv. 12 (1994) 89-101
68. Ericksen B., Wu Z., Lu W., and Lehrer R.I. Antibacterial activity and specificity of the six human α-defensins. Antimicrob. Agents Chemother. 49 (2005) 269-275
69. Stanfield R.L., Westbrook E.M., and Selsted M.E. Characterization of two crystal forms of human defensin neutrophil cationic peptide 1, a naturally occurring antimicrobial peptide of leukocytes. J. Biol. Chem. 263 (1988) 5933-5935